OverviewChartNewsTraderScreen

Titan Pharmaceuticals/  US8883147055  /

IEX
30/04/2024  21:00:34 Chg. - Volume Bid- Ask- High Low
6.71USD - 9
Turnover: 60.35		 -Bid Size: - -Ask Size: - 6.71 6.71
GlobeNewswire 08/02 BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
GlobeNewswire 25/01 Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria
GlobeNewswire 28/12/2023 Titan Pharmaceuticals Announces Reverse Stock Split and Ratio
GlobeNewswire 16/10/2023 Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company'...
GlobeNewswire 09/10/2023 Ashvattha Therapeutics Announces Appointment of Dr. Sakura Minami as Vice President of Translational...
GlobeNewswire 18/09/2023 Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock
GlobeNewswire 18/04/2019 Detailed Research: Economic Perspectives on TransAct Technologies, Lifeway Foods, ImmuCell, Digirad,...
GlobeNewswire 20/03/2019 Global Opioid Use Disorder (OUD) Opportunity Analysis and Forecasts 2018-2027: Experienced and New P...
GlobeNewswire 11/02/2019 Titan Pharmaceuticals Selects Life Sciences Business Intelligence CRM Innovator, TikaMobile, to Empo...
GlobeNewswire 16/08/2018 Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
GlobeNewswire 19/03/2018 Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Dir...
GlobeNewswire 13/10/2017 Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2017 Financial Results and ...
GlobeNewswire 02/10/2017 Opiant Pharmaceuticals and Titan Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use...